Tag Archives: shipments

By Bhanvi Satija and Siddhi Mahatole (Reuters) -Sarepta Therapeutics shares snapped a three-day losing streak on Tuesday, as analysts said resumption of U.S. shipments for its muscular gene therapy soothes immediate concerns about liquidity and the therapy’s withdrawal from the market. The company said on Monday it would resume shipments of Elevidys — approved in the U.S. to treat a …

Total worldwide shipments and digital sales for Elden Ring Nightreign have surpassed five million units, and Elden Ring expansion “Shadow of the Erdtree” has surpassed 10 million units, publisher Bandai Namco and developer FromSoftware announced. Elden Ring Nightreign launched for PlayStation 5, Xbox Series, PlayStation 4, Xbox One, and PC via Steam today on May 30, and surpassed two million …

Thomas Fuller | SOPA Images | Lightrocket | Getty Images Sarepta Therapeutics said on Monday that it will pause all shipments of its Elevidys gene therapy in the United States after a muscular dystrophy patient who received a different, experimental treatment died. U.S. regulators on Friday asked Sarepta Therapeutics to voluntarily halt shipments of its gene therapy. However, the company …

Sarepta Therapeutics Announces Voluntary Pause of ELEVIDYS Shipments in the U.S.  Sarepta Therapeutics In surprise reversal, Sarepta Therapeutics says it will pause shipments of Duchenne gene therapy  statnews.com Sarepta LGMD trials all hit by FDA hold amid newly surfaced safety concerns over gene therapy  Fierce Biotech Sarepta shares plunge 40% as future of its gene therapy appears at risk  CNBC Sarepta Therapeutics stock sinks …

Sarepta plans Elevidys shipments despite FDA request (SRPT)  Seeking Alpha Sarepta Refuses FDA Request to Stop Shipping Muscular Dystrophy Drug Elevidys  The New York Times FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following 3 Deaths  fda.gov We are mothers of Duchenne patients. Recent setbacks with Sarepta must not stop progress  statnews.com Sarepta …

WASHINGTON (AP) — Drugmaker Sarepta Therapeutics said late Friday it won’t comply with a request from the Food and Drug Administration to halt all shipments of its gene therapy following the death of a third patient receiving one of its treatments for muscular dystrophy. The highly unusual move is a latest in a string of events that have hammered the …

Exclusive: US FDA to ask Sarepta to stop shipments of gene therapy Elevidys, source says  Reuters Sarepta shares plunge 40% as future of its gene therapy appears at risk  CNBC FDA to Ask Sarepta to Stop Shipping Muscular Dystrophy Drug Elevidys  The New York Times Third death from a Sarepta gene therapy  BioCentury FDA Is Investigating If Sarepta’s Gene Therapy Should Stay on Market  Bloomberg …

Top Republican on China panel objects to resumption of Nvidia H20 chip shipments  Reuters House China Panel Faults Trump’s Move to Ease Nvidia AI Chip Sales  Bloomberg.com Nvidia CEO Huang Just Met With China’s Commerce Minister. Why the Stock Is Gaining.  Barron’s How Nvidia’s Jensen Huang Persuaded Trump to Sell A.I. Chips to China  The New York Times Trump just handed China a major …